https://wuxibiology.com

WuXi BiologyFrom target discovery & validation, to hit finding and lead optimization, our experts accelerate the selection of your preclinical candidates.WuXi Biology By using this site, you agree to our updated Cookie and Privacy Policy. Skip to content Resources Discovery Biology Library Latest Biological Sciences Biology Webinars Blog News & Events News Upcoming Events Upcoming Webinars About Us 简 WuXi Biology Drug Discovery Services Analytical Services Purification and Structure Elucidation Physicochemical Characterization & Compound Validation Pharmaceutical Analysis and Quality Control Mass Spectrometry Services Hit Finding and Screening Services ASMS Screening DNA-Encoded Libraries (DEL) Fragment Screening & FBDD High-throughput Screening (HTS)  Virtual Screening Integrated Drug Discovery Integrated Platforms Project Management Discovery Chemistry Structure Based Drug Discovery Protein Production FBDD – Fragment Screening Biophysical Assays and Screening Biopharmaceutical Assays CryoEM X-ray Crystallography Biology Services Structural Biology Protein Production FBDD – Fragment Screening Biophysical Assays and Screening X-ray Crystallography CryoEM Microscale Thermophoresis Biophysical Assays for Drug-Target Interactions In Vitro Biology Assay Development Biochemical Assays Immune and Cell-Based Assays In Vitro Toxicology and Safety Pharmacology Screening In Vivo Pharmacology Cardiovascular Diseases Models CNS Models Fibrosis Disease Models Inflammation Models Kidney Disease Models Liver Disease Models Pain Models Tumor Models Oncology and Immunology Tumor Models Immuno-oncology Cancer Cell Panel & In Vitro Oncology Assays Translational Oncology Immune profiling | Biomarker platforms OncoWuXi Database Solutions Phase Target Identification and Validation Hit Finding Hit to Lead Lead Optimization Candidate Selection IND Submission Platforms Structure Based Drug Discovery Screening Platform Biology Platforms In Vitro Biology Pharmacology Studies Toxicology Platform Drug Metabolism and Pharmacokinetics Translational Platform Biomarker Platform Therapeutic Areas Autoimmune and Inflammatory Diseases Cardiovascular & Metabolic Diseases Central Nervous System and Pain Infectious Diseases Liver Diseases Oncology & Immuno-oncology Respiratory Diseases Therapeutic Modalities Antibody Drug Conjugates CAR-T Cell Therapy Natural Products Oligonucleotides Oncolytic Viruses Peptides Targeted Protein Degradation Resources Discovery Biology Library Latest Biological Sciences Biology Webinars News & Events News Upcoming Events Upcoming Webinars About Us Contact Us Contact Us Homepage On-Demand Webinar: Empowering Early Discovery of Peptide Drugs Learn about recent advancements in peptide drug discovery and strategies that are crucial for developing potent and orally available peptide drugs. View the Video Publication: A µ-Opioid Receptor Modulator that Works Cooperatively with Naloxone Learn how researchers successfully identified selective negative allosteric modulators for the μ-opioid receptor using DNA-encoded library (DEL) technology Read Abstract Publication: USP7 Inhibitors Reveal a Mechanism of p53-Driven Anticancer Activity Learn about the mechanistic differences between USP7 and MDM2 inhibitors and their effects on p53 signaling. Access Full Article WuXi Biology A full spectrum of biology services and solutions, supporting stand-alone and integrated projects, from target discovery to candidate selection and into the clinic Learn More Enabling Unbounded Possibilities WuXi Biology provides a full spectrum of services and solutions to support stand-alone and integrated projects, from target discovery to candidate selection and into the clinic. Our world-class discovery platform is backed by nearly 3000 scientists, offering expertise in all major disease areas and target classes, across all therapeutic modalities. From small molecules, oligonucleotides, and peptides to antibodies, cell, and gene therapies, our state-of-the-art services, fast turnaround times, and quick study launches meet the diverse needs of our clients. Speak with a Specialist Hit Finding Customized hit identification and screening solutions to enable rapid drug discovery success. Hit Finding Integrated Drug Discovery Expertise in synthetic and medicinal chemistry, biology, DMPK and program management for drug discovery. Integrated Drug Discovery Discovery Biology A full spectrum of biology services and solutions from target discovery to candidate selection and into the clinic. Discovery Biology Analytical Services High quality integrated analytical services in a rapid & cost effective manner Analytical Services Oncology Research Comprehensive biology platform to accelerate discovery and development of new oncologic therapies. Oncology Research Target Discovery to Candidate Selection and BeyondSupporting stand-alone and integrated projects Comprehensive platform from target ID to drug candidates Target Identification and ValidationFinding druggable targets Comprehensive coverage of target classes and therapeutic modalities Hit IdentificationScreening services to accelerate drug discovery Integrated platform with diverse methods to identify hit compounds Hit Validation and Early OptimizationConfirming chemistry tractability In vitro screening platform to support medicinal chemistry Lead Discovery ServicesEnhancing the most promising compounds In vivo services to accelerate drug discovery Preclinical Drug DevelopmentEnabling the selection of the best candidates Integrated platform for preclinical R&D to accelerate timelines Investigational New Drug DiscoveryComprehensive IND enabling testing platform Supporting clients from research to market Latest Science Latest Poster TLR8 Mouse Model to Evaluate anti-HBV Agents TLR8 Mouse Model to Evaluate anti-HBV Agents VIEW Poster Latest Publication Discovery of Potent, Selective, and Orally Available IRE1... Discovery of Potent, Selective, and Orally Available IRE1 alpha Inhibitors VIEW Publication Latest Publication Discovery of SARS-CoV-2 Papain-like Protease Inhibitors Papain-like Protease Inhibitors VIEW Publication Latest Publication Novel DEL Hit That Binds in the Cbl-b... Novel DEL Hit That Binds in the Cbl-b SH2 Domain VIEW Publication Latest Publication Cardiac Manifestations of Fabry Disease Cardiac manifestations of Fabry disease VIEW Publication Latest Publication Pharmacodynamic and Pharmacokinetic Profile of a Novel GLP-1... Novel GLP-1 Receptor Biased Agonist VIEW Publication Latest Publication USP7 Inhibitors Reveal a Differentiated Mechanism of p53-Driven... Differentiated Mechanism of p53-Driven Anti-Cancer Activity VIEW Publication Latest Publication Preclinical Evaluation of the SARS-CoV-2 Mpro Inhibitor RAY1216 Mpro inhibitor RAY1216 VIEW Publication Latest Publication A µ-Opioid Receptor Modulator that Works Cooperatively with... Receptor Modulator that Works Cooperatively with Naloxone VIEW Publication Latest Poster mRNA-Encoded Modulators Suppress Tumor Growth mRNA-Encoded Modulators Suppress Tumor Growth VIEW Poster Previous Next × Contact An Expert Today! Contact Us Want toKnow More? Contact Us Subscribe to Our Newsletter Follow Us on LinkedIn Drug Discovery Services Analytical Services Hit Finding and Screening Services Integrated Drug Discovery Structure Based Drug Discovery Biology Services Structural Biology In Vitro Biology In Vivo Pharmacology Oncology and Immunology Solutions Phase Platforms Therapeutic Areas Therapeutic Modalities Resources Discovery Biology Library Latest Biological Sciences Biology Webinars News & Events News Upcoming Events Upcoming Webinars About Us Contact Us Contact Us +1 857-413-2800 (U.S.) +86 (21) 2066-3734 (Global) © 2024 WuXi AppTec   Terms of Use   |   Privacy Policy   |   沪ICP备10016157号-29   |   沪公网安备31011502018748号   |   Consent Preferencesenusen-US1729051801https://wuxibiology.com

Modifier votre site ?

Que fais-tu?